Literature DB >> 8500778

Antimicrobial activity determined in strains of Bacillus circulans cluster.

C Perez1, C Suarez, G R Castro.   

Abstract

Wild-type strains of the genus Bacillus were screened for antimicrobial activity. Two strains exhibited antimicrobial activity against Micrococcus luteus and were identified as Bacillus polymyxa MIR-23 and Bacillus circulans MIR-13. Bacillus polymyxa MIR-23 was active against Escherichia coli, Pseudomonas aeruginosa and Aspergillus niger, whereas Bacillus circulans MIR-13 did not show activity against these microorganisms. Bacillus subtilis ATCC 6633 and B. polymyxa ATCC 10401 were used as standard antibiotic-producer strain and showed different antimicrobial profiles and yields from B. polymyxa MIR-23. The different antimicrobial profile of the two selected strains could possibly be used as a taxonomic marker.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500778     DOI: 10.1007/BF02814544

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  7 in total

Review 1.  Molecular biology of antibiotic production in Bacillus.

Authors:  M M Nakano; P Zuber
Journal:  Crit Rev Biotechnol       Date:  1990       Impact factor: 8.429

Review 2.  Biosynthesis of peptide antibiotics.

Authors:  H Kleinkauf; H von Döhren
Journal:  Annu Rev Microbiol       Date:  1987       Impact factor: 15.500

Review 3.  The peptide antibiotics of Bacillus: chemistry, biogenesis, and possible functions.

Authors:  E Katz; A L Demain
Journal:  Bacteriol Rev       Date:  1977-06

Review 4.  Effect of primary metabolites on secondary metabolism.

Authors:  S W Drew; A L Demain
Journal:  Annu Rev Microbiol       Date:  1977       Impact factor: 15.500

5.  A numerical classification of the genus Bacillus.

Authors:  F G Priest; M Goodfellow; C Todd
Journal:  J Gen Microbiol       Date:  1988-07

6.  Carbenicillin resistance in Pseudomonas aeruginosa from clinical material.

Authors:  J H Darrell; P M Waterworth
Journal:  Br Med J       Date:  1969-07-19

7.  Production of antimicrobials by Bacillus subtilis MIR 15.

Authors:  C Perez; C Suarez; G R Castro
Journal:  J Biotechnol       Date:  1992-11       Impact factor: 3.307

  7 in total
  7 in total

1.  Probiotics in the intestinal tract of juvenile whiteleg shrimp Litopenaeus vannamei: modulation of the bacterial community.

Authors:  Irasema E Luis-Villaseñor; Thelma Castellanos-Cervantes; Bruno Gomez-Gil; Angel E Carrillo-García; Angel I Campa-Córdova; Felipe Ascencio
Journal:  World J Microbiol Biotechnol       Date:  2012-11-18       Impact factor: 3.312

2.  Antagonistic and antimicrobial activities of some bacterial isolates collected from soil samples.

Authors:  S Ghai; S S Sood; R K Jain
Journal:  Indian J Microbiol       Date:  2007-06-14       Impact factor: 2.461

3.  Inhibitory activity of probiotic Bacillus subtilis UTM 126 against vibrio species confers protection against vibriosis in juvenile shrimp (Litopenaeus vannamei).

Authors:  José Luis Balcázar; Tyrone Rojas-Luna
Journal:  Curr Microbiol       Date:  2007-08-07       Impact factor: 2.188

4.  Preliminary characterization of the probiotic properties of Candida famata and Geobacillus thermoleovorans.

Authors:  A Mahdhi; Z Hmila; A Behi; A Bakhrouf
Journal:  Iran J Microbiol       Date:  2011-09

5.  Characterization of Lipopeptide Biosurfactants Produced by Bacillus licheniformis MB01 from Marine Sediments.

Authors:  Yulin Chen; Shiliang A Liu; Haijin Mou; Yunxiao Ma; Meng Li; Xiaoke Hu
Journal:  Front Microbiol       Date:  2017-05-16       Impact factor: 5.640

6.  Antimicrobial Potential of Bioactive Metabolites and Silver Nanoparticles from Bacillus spp. and of Some Antibiotics Against Multidrug Resistant Salmonella spp.

Authors:  Bukola Christianah Adebayo-Tayo; Oluwadara Ekundayo-Obaba; Olutayo Israel Falodun
Journal:  Turk J Pharm Sci       Date:  2020-10-30

7.  Optimizing and purifying extracellular amylase from soil bacteria to inhibit clinical biofilm-forming bacteria.

Authors:  Rokaia Elamary; Wesam M Salem
Journal:  PeerJ       Date:  2020-11-02       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.